RET Gene Abnormalities and Thyroid Disease: Who Should be Screened and When
Mutations in the RET proto-oncogene have been implicated in the pathogenesis of several forms of medullary thyroid cancer (MTC). Multiple endocrine neoplasia type 2 (MEN-2) is an autosomal dominant syndrome caused by germline activating mutations of the RET proto-oncogene and has been categorized in...
Main Authors: | Salehian, Behrouz, Samoa, Raynald |
---|---|
Format: | Online |
Language: | English |
Published: |
Galenos Publishing
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608003/ |
Similar Items
-
Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.
by: Santoro, M., et al.
Published: (1993) -
The Role of Helicobacter pylori Seropositivity in Insulin Sensitivity, Beta Cell Function, and Abnormal Glucose Tolerance
by: Malamug, Lou Rose, et al.
Published: (2014) -
Pediatric Thyroid Disease: When is Surgery Necessary, and Who Should be Operating on Our Children?
by: Breuer, Christopher, et al.
Published: (2013) -
Effect of 3′UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma
by: Ceolin, Lucieli, et al.
Published: (2016) -
On the RET Rearrangements in Chernobyl-Related Thyroid Cancer
by: Jargin, Sergei V.
Published: (2012)